Drugs / Optivate
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02250508 | Dec 2004 → Jun 2005 | von Willebrand disease (hereditary or acquired) | Bio Products Laboratory | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT00387192 | Nov 2006 → Sep 2008 | von Willebrand disease (hereditary or acquired) | Bio Products Laboratory | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT02246894 | Nov 2003 → Jan 2005 | hemophilia A | Bio Products Laboratory | Completed | No outcome recorded |
| Phase 3 | NCT02250482 | Nov 2001 → Aug 2003 | hemophilia A | Bio Products Laboratory | Completed | No outcome recorded |
| Phase 3 | NCT02246881 | Oct 2001 → Jan 2004 | von Willebrand disease (hereditary or acquired) | Bio Products Laboratory | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01811875 | Nov 2014 → Aug 2017 | hemophilia A | Bio Products Laboratory | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01051076 | Nov 2009 → Oct 2020 | severe hemophilia A | City of Hope Medical Center | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01051544 Comparator | Sep 2009 → Jun 2020 | severe hemophilia A | City of Hope Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Optivate | “Optivate” NCT01051076 ↗ |
| Known as | Human Coagulation Factor VIII | “Optivate® (Human Coagulation Factor VIII)” NCT02250482 ↗ |
| Modality | Protein / enzyme biologic | “Plasma-derived Factor VIII” NCT00387192 ↗ |
| Route | Intravenous | “single IV infusions” NCT02250508 ↗ |